News > Advances in Supportive Oncology

With great success, for the 7th consecutive year, the informative and educational two-day conference organized by the Hellenic Society for the Study of New Drugs in Oncology was held, in scientific collaboration with the Oncology Department of the 417 N.I.M.T.S Hospital and the 4th Oncology Clinic of “Errikos Dunant” Hospital.

As Presidents Drs. Tryfonopoulos and Tsoukalas noted, developments in Oncology are continuous and rapid. The contribution of genetics, molecular biology, and bioinformatics is pivotal.

I would like to sincerely thank the Presidents, Medical Oncologists Drs. N. Tsoukalas and D. Tryfonopoulos, for the honor and invitation to chair the session “Advances in Supportive Oncology.” It was an excellent session that covered key topics such as myelotoxicity, cancer-associated thrombosis, mucositis, and oral complications.

My thanks also to the co-chairs, Medical Oncologists Drs. I. Varthalitis and E. Res, and my warmest congratulations to the speakers.

With great honor,
Ourania Nikolatou-Galiti

Professor Nikolatou-Galiti is co-founder and scientific director of the mycancer platform — a space where patients, families, and healthcare professionals have access to education, support, and tools that aim to improve outcomes and protect quality of life.